We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

23 hedge funds and large institutions have $10.8M invested in ImmuCell in 2019 Q2 according to their latest regulatory filings, with 2 funds opening new positions, 6 increasing their positions, 4 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% more repeat investments, than reductions

Existing positions increased: 6 | Existing positions reduced: 4

1% more capital invested

Capital invested by funds: $10.7M → $10.8M (+$133K)

0% more funds holding

Funds holding: 23 → 23 (0)

0% more first-time investments, than exits

New positions opened: 2 | Existing positions closed: 2

0.25% less ownership

Funds ownership: 23.3% → 23.04% (-0.25%)

Holders
23
Holders Change
–
Holders Change %
0%
% of All Funds
0.5%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
2
Increased
6
Reduced
4
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$101K
2
EVC
Eidelman Virant Capital
Missouri
+$88.8K
3
ISL
Ingalls & Snyder LLC
New York
+$30K
4
Wells Fargo
Wells Fargo
California
+$12.4K
5
UBS Group
UBS Group
Switzerland
+$8.32K

Top Sellers

Rank Fund Capital Flow
1
HPC
HM Payson & Co
Maine
-$146K
2
PCM
Perritt Capital Management
Illinois
-$146K
3
CH
CVI Holdings
Delaware
-$64K
4
Morgan Stanley
Morgan Stanley
New York
-$4.44K
5
TRCT
Tower Research Capital (TRC)
New York
-$4.16K
Name Holding Trade Value Shares
Change 		Change in
Stake
Wellington Management Group
1
Wellington Management Group
Massachusetts
$4.44M – – –
HA
2
Heartland Advisors
Wisconsin
$1.3M – – –
PCM
3
Perritt Capital Management
Illinois
$845K -$146K -23,000 -15%
AC
4
Antara Capital
New York
$682K – – –
ISL
5
Ingalls & Snyder LLC
New York
$626K +$30K +4,732 +5%
Vanguard Group
6
Vanguard Group
Pennsylvania
$611K +$101K +15,885 +20%
Renaissance Technologies
7
Renaissance Technologies
New York
$598K +$4.44K +700 +0.8%
WC
8
Wexford Capital
Florida
$585K – – –
SRC
9
Shufro Rose & Co
New York
$329K – – –
HPC
10
HM Payson & Co
Maine
$185K -$146K -23,000 -45%
EFS
11
Essex Financial Services
Connecticut
$137K – – –
MA
12
Minerva Advisors
Pennsylvania
$95K – – –
EVC
13
Eidelman Virant Capital
Missouri
$91K +$88.8K +14,000 New
Morgan Stanley
14
Morgan Stanley
New York
$86K -$4.44K -700 -5%
RC
15
RBF Capital
California
$85K – – –
UBS Group
16
UBS Group
Switzerland
$35K +$8.32K +1,311 +33%
Bank of America
17
Bank of America
North Carolina
$20K +$438 +69 +2%
FHA
18
Flagship Harbor Advisors
Massachusetts
$19K – – –
Wells Fargo
19
Wells Fargo
California
$13K +$12.4K +1,950 New
BlackRock
20
BlackRock
New York
$12K +$2.63K +415 +29%
Citigroup
21
Citigroup
New York
$6K – – –
Northwestern Mutual Wealth Management
22
Northwestern Mutual Wealth Management
Wisconsin
$1K – – –
CH
23
CVI Holdings
Delaware
– -$64K -10,000 Closed
TRCT
24
Tower Research Capital (TRC)
New York
– -$4.16K -655 -92%

ICCC Hedge Fund Activity: Q2 2019 in Review

23 of the 4,605 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2019, worth a combined $10.8M — up 1.2% from $10.7M a quarter earlier.

Fund positioning in ICCC was balanced in Q2 2019: 2 funds opened new positions, 2 closed out, 6 added to existing stakes and 4 trimmed.

The largest buyer was Vanguard Group, adding an estimated $101K. The largest seller was HM Payson & Co, cutting an estimated $146K.

  • 23 institutional investors held ImmuCell (ICCC) as of Q2 2019, unchanged from Q1 2019.
  • Funds reported $10.8M of ImmuCell stock for Q2 2019, up 1.2% quarter-over-quarter.
  • 2 funds opened new ImmuCell positions in Q2 2019 and 2 closed out, a net change of 0 holders.
  • The largest ImmuCell buyer in Q2 2019 was Vanguard Group, an estimated $101K added.
  • The largest ImmuCell seller in Q2 2019 was HM Payson & Co, an estimated $146K sold.

Based on aggregated 13F filings for Q2 2019.